Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

OC DZ 3rd year > Final > Flashcards

Final Flashcards

1
Q

How to reduce progression in glaucoma?

A

IOP control. No longer part of glaucoma definition.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

GLT

A

Glaucoma Laser Trial. Argon laser trabeculoplasty vs. topical meds. Found that ALT is at least as efficacious as topical medical therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Laser trabeculoplasty options

A

ALT, SLT, MLT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

MLT

A

Adjustable pulse diode laser. Allows for cooling affect. Multiple doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AGIS. What did it ask

A

Advanced Glaucoma Intervention Studies. How to treat advanced glaucoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Groups in Agis

A
  1. ALT-trabeculectomy-trabeculectomy 2. Trabecultecomty-ALT-Travecultectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Result of AGIS

A

VF worsened in all groups except in the 100% <18. . Progression halted if IOP reduced by 38-46% and IOP kept below 18 with a mean of 12.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

EMGT

A

Early manifest glaucoma trial. 1. ALT and topical betaxolol. 2. observations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

EMGT results

A

Less progression with treatment. CCT was risk factor for high IOP. Each 1 mm hg of higher IOP gaze a ratio of 1.13 for progression of POAG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CIGTS

A

Collaborative Initial Glaucoma Treatment Study. Looked at filtration surgery vs. meds. Less progression with meds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

OHTS

A

Ocular hypertension treatment study.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

OHTS outcome

A

more progression in observation. CCT is greatest risk factor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CGS

A

Canadian Glaucoma Study. Look at risk factors for VF progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CGS results

A

1 mm HG increase in pressure has increased glaucoma risk. Female, abnormal baseline anticardiolipodiman, age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DIGS

A

Diagnostiic Intervations in Glaucoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DIGS

A

Just followed the patient with no tx. 25% progression. CCT, age, IOP, C/D, and PSD were the risk factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

EGPS

A

European Glaucoma Progression Study. Looked at dorzolamide vs. observation. No difference in progression between the two.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CNTGS

A

Collaborative Normotensive Glaucoma Study. 1. Topical meds or surgery 2. observation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CNTGS results

A

Less progression with tx. Women, migraine suffers, and patient who present with disc hemorrhages are at greater risk of progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

LoGTS

A

Low pressure glaucoma treatment study. Compare brimonidine to timolol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

LoGTS results

A

similar efficacy. Less progression with brimonidine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

NYGS

A

New York Glaucoma Study. Mean IOP and Peak IOP fluctuations associated with VF progression. 1mmHG increase glaucoma progression by 10%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Key clinical points from landmark studies

A
  1. 1 mm hg increase is 10% risk. 2. Glaucoma progression decreased if 20-30 reduction. 3. Halted if below 18.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Causes of POAG and OHTN

A

50% have >21 mm HG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Why progress of glaucoma even with TX

A

Undetected IOP spikes, noncompliance, increased suspectiblity of the lamina cribosia, other processes outside of IOP that damage ganglion cells (premature apoptosis, insufficient ocular perfusion, neurodegenerative process)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Most important non ocular risk factors in glaucoma

A

Family history, Age, Race (black)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Most important ocular risk factors

A

Large C/D, Elevation IOP, Thin Corneas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

When is IOP highest

A

during the night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Corneal hysteresis

A

The pressure when bend cornea with puff and then bends back. 10. Lower is higher risk for glaucoma. Decreases with age. Lower in keratoconus, glaucoma, and fish’s corneal dystrophy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What RE is most likely to get glaucoma

A

Myopia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Diastolic Perfusion Pressure

A

Lower is greater risk of glaucoma. <30? Decreases at night time as well as blood pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Vascular risk factors and glaucoma

A

increased risk with migraine, low profusion to fingers, nocturnal hypotension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

40 micrometers decrease in CCT equal

A

71% glaucoma risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

When to tx for glaucoma

A
  1. change in VF or ON 2. wants it 3. vascular dz with dance or vascular occlusion 4. Iop above 30
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

CRVO

A

Twice as likely to occur in an eye with glacumotous cupping.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Guidelines for IOP target

A

decrease by 20%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Early glaucoma

A

deficiencies in optic nerve that are char. of glaucoma but no VF changes or only changes with short wavelength or frequency doubling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Moderate glaucoma

A

ON deficients and VF defect in 1 hemifield but not within 5 degrees of fixations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Late glaucoma

A

ON deficients and VF defects in both hemifields and/or within 5 degrees of fixations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Target IOP guidelines

A

If >32 low 20s, if risk >21, VF loss >18 with glaucoma early, Moderate to advanced with VF loss >15, Advanced with central loss >12.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Glaucoma masqueriders

A

MOATVP MS, Optic nerve compression, AION, Tramatic ON, Vascular occlusion, pan retinal photocoagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

2.5 ml

A

1gtt qd for 1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Trialing rxn

A

2-3 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

How long to wait between gets?

A

5 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Prostaglandin

A

First drug for glaucoma. Latanoprost typically. 20-30% decrease. QHS (every night at bed time) Increases uveosclearl output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

SE of prostaglandin

A

hyperemia, hyerchiasis (eyelashes), hyper pigmentation around lower lid and iris, and reduced periorbital fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Very Rare SE of prostaglandin

A

CME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Prostaglandin and Cataract surgery

A

stop 7-10 days before and put on CAI or alpha agonist. Continue 4-6 weeks after.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

what prostaglandins are CI

A

latanoprost and bimatoprost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

what to do if not getting desired decrease in IOP with prostaglandin

A

There is no increase effect with increased dosing. Should do an in class switch before adding another (no L and B)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

How many patients need another treatment within 1 year of starting prostaglandin tx

A

30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Beta blockers

A

20-30%. Decrease aqueous humor production. qam or bid. work poor at night.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

PGA bottle color

A

turqoise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

BB bottle color

A

blue or yellow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

CAI

A

amide. tid or bid. decrease aqueous production. 20-30%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

CAI bottle color

A

orange.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Sulfa allergy and CAI

A

Less concerned with CAI. More worried with adrenergic agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

CAI adverse rxn

A

Guttate with fuch’s can cause cornea to become opaque. Do not use with any patients with endothelial defects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Alpha 2 Adrenergic Agonist

A

dine. 20-25%. bid or tid. decrease aqueous and increase uveosclera.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

SE alpha 2 adrenergic agnoist

A

allergic response in 10-20 Brimonidine and 48 Apraclonine. Can also cause vasoconstriction, pupillary dilation, eyelid retraction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

CI of alpha 2 adrengerics

A

MAOIS and TCAs. Both for depression. Effect on perfusion pressure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Miotic

A

Pilocarpine. 20-25%. Increase outflow by normal way. qid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

PGA peak effect

A

2 weeks, stabilize at 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

BB peak effect

A

4-6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

CAI peak affect

A

3 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

A2 agonist peak affect

A

2 weeks, stabilize at 6 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Mioticic peak affect

A

3 hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

Glaucoma suspects follow up

A

Depends on severity by 6-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Stable mild glaucoma

A

4-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

Stable moderate glaucoma

A

2-4 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

stable severe stage

A

1-3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

unstable with progression

A

1-2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

recently established stability

A

1-3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

How often to do gonio on FU

A

2-5 years on all but poor controled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

ON/RNFL photography on FU

A

Annual for all but unstable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

VF FU

A

Annual for suspect nd mild. a6m for moderate. q3-4 months for sever. q1-2m for unstable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

OCT FU

A

Annual for suspect and mild. q6m for moderate, q3-4 months for severe. q1-2 months for unstable.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

Deepening of scotoma

A

Two or more points 10 db or poorer in the same location as the baseline scotoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Expansion of scotoma

A

2 or more points 10 db poorer adjacent to the baseline scotoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

New Scotoma

A

2 or more adjacent points not within or adjacent to the baseline scotoma now showing a probability on pattern deviation of P<1% or worse. 1 Point within the central 10 degrees that decline by 10 db in a previously normal location.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Progression with previously normal VF

A

Abnormal glaucoma hemifield test, PSD abnormal at 5% level, single point P<0.5%, 2 clustered points with P<5% with one point worse than P<1%. 3 or more clusters worse than P<5%. Needs to be repeatable, 2 or more times.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

When do you get floor effect

A

54-55 um. Later monitor with VF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

which one to not add to prostaglanidn

A

Alpha 2 agonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Cosopt

A

Timolol and drozolamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Combigan

A

Timolol and briminodine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Simbrinza

A

Brimonidine and brinzolamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

ALT vs SLT

A

SLT easier 180-360 and can perform in same spot. ALT is 180 and final

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Pre-operative for laser trabeculoplasty

A

pilocarpine 10 minutes prior. 1 gtt. brimonodine or apracolodine during procedure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Post-op for LT

A

Check pressure after 1 hour. If >8 add glaucoma drop. Check 1 day then 1-3 weeks. Takes 3 months for effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

SE of LT

A

Pain, inflammation (topical steroid aid for 4-5 days) scaring of TM and PAS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

Possible mechanism of ALT

A

Mechanical: contract tissue and open up flow. Biological: increase cellular activity of TM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

Possible mechanism of SLT

A

Biological: increase chemocatic and vasoactive agent which increase outflow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

MLT

A

Less damage than ALT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

TSLT

A

No damage to TM.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

Who to perform LTP

A

elderly, POAG, pigmentary, pseudo exfoliative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

LTP effectiveness

A

SLT and ALT equal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

Pretreatment of SLT

A

360 pretreatment has 15% decrease. Can do over an ALT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

States with laser privledges

A

Louisiana, Kentucky, Oklahoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Trabeculectomy

A

create a passage for drainage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

PO for traveculectomy

A

AB qid for 2 weeks, steroid q2hours during waking hours for 2 weeks and then taper for 4-8 weeks, atropine qd-bid for 2 weeks. Close monitoring of pain and IOP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

IOP decrease in trabeculectomy

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Complications of trabeclectomy

A

uveitis, enophthamitis, hyphen, underdraining, overtraining, aqueous misdirection, reduced VAs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

Managing a leaking blob

A

Manage IOP with BB or CAI, pressure patch or CL, apply AB, make sure eye has moisture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

Later complication with trabeculectomy

A

cataract formation, blebitis, ptosis, persistent leak. . Bleb scaring so it won’t leak. Use antimetabolites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

Risk factors for failure with traveculectomy

A

Age <40, black, prior failed surgery, aphasia or psudophakia, neovascular glaucoma, inflammatory glaucoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

Happy bleb

A

shallow, widespread, pale but not avascular, upper lid, has micro cysts, no side.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

Choroidal Effusion

A

serous fluid in suprachoidal space. Myopic shift, scotoma, If hemorrhagic: onset pain with decreased VA, high IOP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

What causes choroidal effusion

A

Low IOP and inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

TX for choroidal effusion

A

address the cause, cycloplegia if AC shallow, topical steroid for inflammation, with hemorrhagic IOP reduction needed with topical and oral IOP meds.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

Vision loss with trabeculectomy

A

56% transient. 8% permanent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

bleb needling

A

when you want to increase flow with trabeculectomy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

Shunt.

A

similar to trabeculectomy. Bleb is still needed but no iridotmy. Less complications and failures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

Tube vs shunt

A

Tube: high risk glaucoma, uveitis, ICE syndrome, aphasia. Need for surgery in the future. Poor compliance (Fu not as important as with trap) TRAB: severe disease or phakic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

Canoloplasty

A

360 tubing of scheme’s canal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

Pros of canoloplasty

A

non pentrating, no bleb, less post operative mgmt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

Cons of conoloplaty

A

cannot perform if any damage to scheme’s canal, not as significant of a decrease, CI in narrow angles, (SLT is okay),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

CI of canoloplasty

A

angle closure, narrow angle, neovascularization, post traumatic glaucoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

Trabectome

A

abates TM with cataract surgery. CI with cloudy cornea, large drop will occur, narrow angles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

cycloablation

A

used as last resort. CB is damaged. 50 to 85% reduction. Controls post op inflame with prednisone acetate.

120
Q

cycloablation SE

A

40% have vision loss.

121
Q

Lattice degernation

A

Thinning of inner retinal layers. Overlying packet of liquefied vitreous. Condense vitreous fibers attached at edge. 10-12% of eyes. 40% had RD.

122
Q

When to tx lattice degernation

A

flashing lights, fellow eye suffered RD.

123
Q

Cystic Retinal Tufts

A

Congenital lessions. Discrete tuffs of tissue extending into the vitreous. If symptomatic treat. Can have tractional retinal flaps, adjacent atrophic holes, percolated tears.

124
Q

Atrophic retinal holes

A

well defined hole in periphery. Scleral depression to diff. from hemorrhage. Any symptoms and treat.

125
Q

White without pressure

A

bilateral and symmetric in most cases.

126
Q

When to refer with lattice degenreation

A

flashing lights or pigment cells in viterous

127
Q

When to refer with cystic retinal tufts

A

status of fellow eye, family history of RD.

128
Q

Rhegmatogenous retinal detachment

A

Associated with a retinal tear. Myopic patient and lattice degernation.

129
Q

Regmatogenous RD signs

A

pale or opaque, corrugated surface, loss of choroidal detail, retinal vessels appear darker due to ischemia and becoming engaged, lower IOP than fellow eye,

130
Q

Cryotherapy or laser photcoagulation

A

Use with regmatogenous RD. Seals off spread. Chorioretinal scaring.

131
Q

Scleral Buckling

A

Regmatogenous RD. Occurs with vicetromy. Silicone band around eye. Eye elongated. Inferior retinal detachments good.

132
Q

Pneumatic Retinoplexy

A

in office procedure for regmatogenous RD. Injection of intraocular gas to flatten the retina. Cryotherapy to seal the RT. Limited to superior detachment or a single retinal break.

133
Q

Primary Virectomy

A

Reg. RD. Most common procedure. Outpatient. Vitrectomy in conjunction with a fluid/gas exchange. High incidence of cataracts.

134
Q

Silicone oil

A

Vitreous substitute. Remains in the eye long term. Change in RE. Removal of oil is necessary if complications. Avoid silicone implant lenses. Inferior peripheral iridectomy may have to occur. Complicated RD.

135
Q

Etiologies of tractional RD

A

proliferative retinal vas. dz, proliferative vitreoretinopathy, penetrating ocular trauma.

136
Q

Signs of tractional retinal detachment

A

opaque, absence of choroidal detail, immobile, overlying fibrosis obscures underlying retinal vessels.

137
Q

tx for tractional RD

A

vitrectomy with stripping off of the overlying fibrotic tissue, silicone oil.

138
Q

exudative RD

A

Fluid accumulated under the retina from a pathological lesion.No retinal break.

139
Q

Etiologies of exudative RD

A

Retinal hemangioma, coat’s disease, choroidal tumors, posterior uveitis (toxo). Severe AMD.

140
Q

SX of exudative RD

A

shadows relative to elevated area, fluid shift with head position

141
Q

TX for exudative RD

A

directed at underlying pathology. Commonly laser or cryotherapy.

142
Q

RD referal

A

Macular on same day.

143
Q

Macula off

A

within 48 hours.

144
Q

Retinoschisis

A

5% population, 70% hyperopic, IT most common, BILATERAL.

145
Q

Signs of retinoschisis

A

smooth cantor, transparent, immobile, NO demarcation line.

146
Q

Demarcation line

A

pigment line that forms on the posterior margins of RD signifying the chronic presence of sub retinal fluid.

147
Q

TX for retinocschisi

A

Laser photocoagulation.

148
Q

Choroidal detachment

A

Elevated retinal area, brown or dark in color, abrupt transition with attached retinal, lower intraocular pressure, post surgical.

149
Q

tx for choroidal detachment

A

topical steroids, topical cylcoplegics, oral steroids, surgical drainage.

150
Q

Patient presenting with angle closure

A

Mid dilated pupil not reactive to light, gimbal hyperemia, cloudy cornea, closed angles with gonio, IOP 40-90.

151
Q

Signs Symptoms

A

blurred vision, photophobia, halos, pain, nausea, HA, eye redness.

152
Q

Primary angle closure suspect (PACs)

A

Likely apposition between peripheral iris and posterior TM without elevation of IOP or PAS.

153
Q

PAC

A

narrow angles and apposition to angle be peripheral apposition or synechial angle closure

154
Q

PACG

A

PAC with ON changes.

155
Q

Gonioscopy tips with ACG

A

Dark room, 4 mirror without flange for indention, narrow slit with reduced light intensity, with steep insertions you can tilt mirror to the angle.

156
Q

Dark room infrared gonio

A

perform without light to see worst case scenario.

157
Q

Anterior segment OCT

A

Can be utilized in the dark, only able to appreciate the general structures, education tool. No touching the eye

158
Q

How common is angle closure glaucoma to POAG

A

1/3 but equal number blind.

159
Q

Epidemiology of ACG

A

Asian and Intuit women!

160
Q

Risk factors for ACG

A

Shallower ACA, thicker lens, shorter axial length.e. hyperopia. Women at higher risk. Greater risk at 55.

161
Q

If presenting like ACG but under 55

A

likely it is plates iris syndrome. When AC is deep but the angle is narrow. Angle is open and narrow when pupil is small and closed wen pupil is dilated.

162
Q

Van herick

A

Chamber depth to corneal thickness: >cornea: 4 1/4-1/2: 3 1/4:2 <1/4:1 slit: very narrow.

163
Q

oblique flashlight

A

If there is a shadow the angle is narrow. If there is no shadow it is open.

164
Q

Meds to avoid with narrow angles

A

Anticholingerics (antihistamine, motion sickness, bladder control), Adrenergic agonists (decongestants), TAD, antipsychotics, antiparkinson.

165
Q

Acute ACG

A

25%. May occur with dark illumination or drugs. Abrupt increase in IOP. ocular pain. Unilateral. At least 3 of the signs. Microcytic edema on cornea. Ischemia can produce sector atrophy that release pigment, bombe appearance, posterior synechiae. On may be hyperemic and edematous. CRVO may occur. Lens will have glakomflecken.

166
Q

Intermittent ACG

A

Repeated brief episodes of angle closure. Attacks often resolve by going to sleep (mitosis helps with pupil block)

167
Q

Chronic ACG

A

Gradual, asymptomatic closure of angle via formation of PAS. Often appear with VF loss. STNI (most common to least) Asian eyes common.

168
Q

Plateau iris

A

AC appears deep with slit lamp but narrow with gonio. Indentation gonio creates double hump appearance. Less than 50. Still occludable after LPI.

169
Q

Acute angle closure TX

A

Indention gonio may help break attachment. Can break with alpha 2 agonist, Beta Blocker (betaxolol for pulmonary issues), Pilocarpine. Acetazolamide.

170
Q

Who do you not give acetazolamide to

A

sulfa allergy.

171
Q

Oral osmotic agents for AAC

A

If not broken in 1 hour. Glycerol 50% solution. Isosorbide 45% solution. HA diarrhea, Nausea, vomiting. Serve over crushed ice. No water within first 2 hours of drinking.

172
Q

Glycerol 50%.

A

1/5 ml/kg body weight. 5-7.5 per adult. Peak in 45-120 minutes. Careful for ketoacidosis in DM.

173
Q

Isosorbide 45% solution.

A

1/5 ml/kg body weight. Peak in 45-120 minutes. Safe in diabetics.

174
Q

Mannitol

A

diuretic. .5-1.5 g/kg body weight. IV dose. IOP may fall 30 or more. Ci with cardiac or renal DZZ. SE: HA, back pain, diuresis.

175
Q

Indention gonioscopy

A

Indent central cornea for 30 seconds, rest for 30 second then repeat over 10-15 minutes

176
Q

What to do if patient still in closure after 2 hours

A

Laser iridoplasty

177
Q

If patient still has angle closure after 4-6 hours

A

emergency Laser Iridoplasty or surgical iridectomy.

178
Q

Paracentesis

A

Symptoms relief is immediate and resolves quickly. Shallow AC which increase risk as blue enters eye. Choroidal hemorrhage from rapid pressure drop. LPI is still needed.

179
Q

What to do after you control ACG

A

Check IOP q 15-30 minutes. If IOP <20 make sure angle is open. If open maintain patient on 2% pilocarpine and prednisolone acetate 1% until LPI performed.

180
Q

PreOp for LPI

A

Pilocarpine, apraclonidine/bromonodine 1 hour before to control IOP spike, Topical anesthesia. Glycerol if cornea is edematous.

181
Q

Post Op for LPI

A

Measure IOP 1-3 hours, Steroid 1 get qid for 4-7 days, FU in 1 week for gonio. Check at 1,2, and 6 months. Most LPI close in 6-8 weeks.

182
Q

complications with LPI

A

corneal burn, transient IOP increase, cataract progression, post-op inflammation, late closure, hemorrhage, ghost image.

183
Q

Prophylactic LPI

A

Closed in at least 270 degrees or 180 degrees

184
Q

How many PAC patients have another closure in 5-10 years in other eye

A

40-80%

185
Q

Argon laser peripheral iridoplasty

A

Useful in short term IOP lowering. Causes iris to shrink and pull away from angle. Works when IOP still high after LPI. Works for plateau iris.

186
Q

Incisional Perihal iridoectomy

A

Small section of peripheral iris is excised through gimbal incision. When cornea too cloud for LPI. or AC too flat. Also good when ACG persists with LPI and iridoplasty.

187
Q

Goniosynechialysis

A

Can combine with cataract. Replacement of lens stops formation. GO in a break up PAS. 80% success rate if PAS present for less than 1 year.

188
Q

Glaucomatocyclit crisis (posner-Schlossman Syndrome)

A

20-50. Unilateral, recurrent. Ocular hypertension with uveitis (fine keratin precipitates). Blurred vision with haloes, minimal discomfort. ONH damage and VF defects may occur after many.

189
Q

TX for glacumomatocylit crisis

A

topical steroids, topical glaucoma gets (NO PGA). No cycloplegia.

190
Q

Pseudo exfoliative glaucoma

A

Increases with age. Unilateral to bilateral. Find PXE material on pupil margin and on lines, increased pigment inferiorly on gonio. Treat like POAG. Often filtering surgery.

191
Q

Iridocorneal Endothelial Syndromrome (ICE)

A

20-50. F>M. Unilateral. Abnormal corneal endothelium (bronze), iris changes, corneal edema, PAS extending above schwalbe’s line, secondary angle closure glaucoma. Corneal endothelial cells go to TM.

192
Q

TX for ice.

A

OHTN meds, filtering surgery, hyportonic for corneal edema.

193
Q

Malignant glaucoma

A

rare form of glaucoma, typically following glaucoma surgery. High IOP with shallow AC following surgery. Pain and hyperemia. Need to confirm no pupillary block, may occur as long as 1 year after surgery. That that vitreous pushes and moves forward.

194
Q

TX for Malignant Glaucoma

A

Cycloplegia (phenyl and atropine aid), decrease IOP with acetazolamide, BB, AA< CAI. Reduce vitreous volume with mannitol, glycerol, isosorbide, anti-inflammatory.

195
Q

Prognosis of malignant glaucoma

A

50% fix in 5 days.

196
Q

Mobile Lens

A

zones are lax and lens moves forward to to vitreous pressure. TX is lens removal.

197
Q

Uveal Effusion (choroidal effusion)

A

Mobile lens but with anterior rotation of ciliary body. Bilateral. Choroidal effusion often associated with medications (topirmate, sulfonamides, SSRI). TX: cycloplegia, lower IOP, stop causative meds.

198
Q

Steroid Induced Glaucoma

A

Degrade outflow of TM by inhibiting degration of ECMin the TM. Baseline IOP then 2 weeks, then months for 2-3 months and hen 6 months. Steroid response resolves in 1-4 weeks for responds and a few days for acute responders.

199
Q

What percentage of the population is steroid responders.

A

18-36%

200
Q

Are patient with POAG more likely to be steroid responders

A

YES.

201
Q

Neovascular glaucoma

A

Most common causes: CRVO, DR, OIS. Need to have a high index of suspicion. Treat with PRP, IOP lowering meds.

202
Q

Control of Diabetic AC1

A

DCCT: reduces risk of Diabetic retinopathy and slower progression,

203
Q

United Kingdom Prospective Diabetes study (UKPDS)

A

For every percentage of reduction of A1C there was a 35% reduction of risk of microvascular complications.

204
Q

If you decrease you average blood sugar by 30 the AIC goes don by

A

1%

205
Q

How soon should someone with DM I have an eye exam

A

5 years.

206
Q

How soon should someone with DM II have an eye exam

A

Soon. Takes a long time to dx.

207
Q

DMI retinopathy rates

A

After 5 years 25% will have tetonpathy, After 19 years, 60%, after 15, 80%.

208
Q

Is there increased risk of DR with gestational DM

A

No. Ret takes a long time. Greater chance they will get DM later in life though.

209
Q

Is there increased risk of DR if insulin dependent and DM II

A

Yes. Basal levels are poor.

210
Q

Type II DR

A

After 5 years 24% not on insulin and 40% on. After 19 53% not on and 84% on insulin.

211
Q

Pt with DM but no DR

A

FU in 1 year. 5-10% will develop DR in 1 year.

212
Q

Mild NPDR

A

At least one MA. FU in 1 year. DMI: 16% of patient with mild NPDR will progress to PDR in 4 years.

213
Q

Can an MA go away.

A

Yes but this is bad. MeMean that blood flow is stopped at that area.

214
Q

Moderate NPDR

A

Hemmorrhages/microaneurysms worse than 2a and or cotton wool spots. FU in 6 months.

215
Q

Severe NPDR

A
  1. 4 quads of hemorrhages worse than standard photo 2a. 2 quadrants of venous beading worse than standard photo 6b. 1 quadrant of IRMA.
216
Q

High risk for PDR

A

NVD greater than 1/3 disc area, any NVD with vitreous hemorrhage, NVE greater than 1/2 disc area with vitreous hemorrhage,

217
Q

In 4 years, _____ patient with high risk PDR develop severe vision loss

A

44%.

218
Q

PRP

A

Decrease in number of hypoxic cells producing VEGF. Complications are decreases VF, decreased night vision, transient increase in DME, impaired color vision, impaired dark adaption, vitreous hemorrhage.e

219
Q

Gold standard for PDR

A

PRP. Ranizamaub is not bad alternative.

220
Q

CSME

A

Any retinal thickening with 500 of macula, exudates within 500 macula with associated thickening, 1500 of thickening with 1DD of macula.

221
Q

When to think macula thickening on OCT

A

When foveal thickness is greater than 252.

222
Q

Focal on FA

A

Leakage from MA

223
Q

Diffuse on FA

A

MA, retinal capillaries, arterioles.

224
Q

Grid laser

A

Used to treat diffuse. Avoid fovea. RPE cells broken so better can replace

225
Q

Focal laser

A

for focal leakage. Must be 300-500 from macula. Closure with thermal coagulation.

226
Q

Early treatment diabetic retinopathy study

A

Use lasers with 20/40 or worse.

227
Q

Resolve Study

A

CSME fixed with ranizamabut compared to sham.

228
Q

Which anti-VEGF meds is most effective for DME

A

Lucent is (ran)

229
Q

Risk of VEGF

A

Cataract progression, endopthlamos, inflammation,, retinal tracking, stroke.

230
Q

Steroid with DME

A

Works well if you don’t factor in cataracts.

231
Q

Ozurdex

A

Intraviteral implant with dexamethasone. Works 3-6 months and biodegradable.

232
Q

Iluvien

A

intraviteral fluocinolone acetonic. 36 months. not biodegradable. Must check if steroid responder.

233
Q

FAME study

A

FLuroquinole acetate good for DME. Need cataract surgery though.

234
Q

Venous loops and beading

A

Occur next to areas of non profusion. Big predictor of ischemia.

235
Q

IRMA

A

Found near areas of non profusion.

236
Q

Cause of pre retinal hemorrhage in diabetics

A

neovascularization.

237
Q

Pre-retinal hemorrhage

A

If dense and persistent think of vitrectomy. Can also use Yag. Can have traction.

238
Q

Yag and pre-retinal hemorrhage

A

very effective.

239
Q

Diabetic retinopathy vitrectomy study (DRVS)

A

Better if do vitrectomy sooner.

240
Q

Timings for vitrectomy

A

DMI: 1 month. DMII: 2-3 months. Pre-retinal hemorrhage: 1 month.

241
Q

Does aspirin increase hemorrhages in DR

A

NO!

242
Q

Diabetic papillopathy

A

Variant of AION. More commonly bilateral, younger Diabetic pt, minimal to no VA loss, mild to no APD, minimal to no VF defect, insidious onset.

243
Q

Tx for diabetic papillopathy

A

better diabetic control. A dx of occlusion.

244
Q

Why does AV ratio get smaller with atherosclerosis?

A

The walls are thicker so lumen is smaller.

245
Q

What vasculature is tortuous with hypertension

A

arterioles.

246
Q

Artery and vein changes with hypertension

A

Split off at 90 degrees.

247
Q

Stage one of hypertension

A

Decrease in A/V and increased light reflex with atherosclerosis

248
Q

Stage two of hypertension

A

moderate to severe retinal changes. AV nicking

249
Q

stage 3 of hypertension

A

retinal edema, cotton wool spots, hemorrhages.

250
Q

Most common area for BRVO

A

ST.

251
Q

Risk factors for BRVO

A

old age, HTN, DM, Hyperlipedima, oral contraceptive, smoking, inflammatory dz.

252
Q

Acute signs of BRVO

A

dilated and tortuosity of the venous segment of the occlusion. Flame and dot blot hemorrhages, retinal edema, CWS. HypoF due to blockage and capillary drop out, staining of vessel wall.

253
Q

Chronic signs of BRVO

A

Hard exudates, venous sheathing, and sclerosis. Collaterals. Chronic macular edema, neovascarization.

254
Q

Prognosis with BRVO

A

within 6 months 50% have VA of 20/40 or better

255
Q

Ischemic BRVO

A

5DD or greater non perfusion on FA. 40% will develop neovascularization.

256
Q

Tx for neovascularization with BRVO

A

sector PRP.

257
Q

Macular edema with BRVO

A

Grid laser if VA 20/40 or worse after3-6 months or ranibizumab.

258
Q

CRVO non-ischmic

A

Non-ischemic is sudden painless decrease in acuity. Capillary perfusion in FA.

259
Q

CRVO ischemic

A

Sudden decrease in vision, CF or worse. 10DD of capillary non perfusion.

260
Q

What will you see with CRVO

A

Blood and Thunder.

261
Q

Signs of non-ischemic acute CRVO

A

tortuosity and elation of all branches of CRV. Dot blot and flame hemorrhages, macular edema, CWS. FA blockages by hemorrhages, Good retinal capillary perfusion and late leakage.

262
Q

Chronic non-ischemic CRVO

A

Disc collateterals, macular epiretinal gliosis, pigmentary changes, chronic macular edema. Can cover to to ischemic.

263
Q

Ischemic CRVO

A

sudden very bad CF. APD. 10 DD of capillary nonperfusion

264
Q

Signs of acute ischemic CRVO

A

Sever tortuosity of all branches of CRV, extensive dot blot and flame, CWS, ONH swelling and hyperemia.

265
Q

Chronic CRVO

A

disc collaterals, macular epiretinal gliosis, macular pigmentary changes. Chronic macular edema. Iris rubeosis, angle neovascularization. Neovascular glaucoma. Retinal neovasclulzation.

266
Q

Hemiretinal Vein Occlusion

A

Variant of CRVO. ischemic or non. Sudden onset of altitudinal defect. VA reduction variable. Not as common as CRVO but les common than in BRVO.

267
Q

Fern like appearance around macula

A

Ischemic edema.

268
Q

Central Vein Occlusion Study

A

Greater NVI with worse initial VA and less perfusion.

269
Q

Should you treat macular edema from CRVO with grid laser

A

NO!

270
Q

Geneva Study for macular edema

A

Better to start treatment early.

271
Q

Gold standard tx for neovascularization with CRVO

A

PRP.

272
Q

Gold standard for neovascarization with BRVO

A

sector PRP.

273
Q

When to do vitrectomy with BRVO

A

Virtual hemorrhage.

274
Q

FU for nonischemic CRVO

A

FU in 3 months for first 6 months. RTC with problems. Closely monitor for 24 months.

275
Q

FU for ischemic CRVO

A

FU monthly for 6 months, closely monitor for 24 months.

276
Q

Recombinant Tissue plasminogen actibator

A

Breaks up clots

277
Q

Choriorteinal venous anastomosis

A

Allows transretinal retrograde flow of venous blood.

278
Q

Radial optic neuotomy

A

combined vitrectomy and transvitreal incision of nasal scleral ring. Not very often.

279
Q

RAO

A

Atherosclerosis most common with emboli (cholesterol-hollenhorse, fibrin, calcific)

280
Q

BRAO

A

Embolus is main cause. M?F. Older. Sudden a painless altitudinal or sectoral field loss. +RAPD.

281
Q

Where is BRAO most commonly

A

temporal side.

282
Q

BRAO acute

A

attenuation of arteries and veins. Cloudy which edematous retina like triangle, one or more emboli, OCT inner retinal thickening. VF defect that doesn’t recovery

283
Q

Chronic BRAO

A

Retina appears normal, collateral may form, sheathing of arteriole common.

284
Q

BRAO TX

A

no treatment. VA better than CRAO so no maneuvers. Look for emboli cause. 80% to 20/40 or better.

285
Q

CRAO

A

M>F. Unilateral. Sudden profound loss of vision with no pain. Amaurosis fugal can cause. +RAPD.

286
Q

Acute CRAO signs

A

Sliding and segmentation of blood column, cloudy which retina, cherry red spot, peripaillary retina may appear swollen, emboli, OCT shows inner retinal thickening.

287
Q

Chronic CRAO

A

Optic nerve pallor, arterial attenuation, vessel sheathing, patchy inner veinal atrophy, rep changes, NVI, Inner retinal thinning.

288
Q

CRAO TX

A

Attempt within 24 hours. 911. Spin position. Ocular massage. Paracentesis. Aproclinodine, timolol, acetazolamide. Breathing into a paper bag,

289
Q

Prognosis for CRAO

A

Poor.

290
Q

CIRAO

A

Rare. Cilioretinal artery occlusion. Can be alone or with CRVO. Good prognosis.

291
Q

Ocular Ischemic Syndrome

A

Chronic ocular hypo perfusion usually secondary to severe carotid artery obstruction. M. unilateral.

292
Q

Signs of Ocular Ischemic Syndrome

A

Decreased VA, dull ache over brow, variable VF loss. . Neovascarization of iris, neovascular glaucoma, mild iritis, anterior segment reaction and flare. Retinal arterial narrowing, retinal venous dilation without tortuoaisity, neovascularization of the topic disc, cherry read spot, cotton wool spot, macular edema.

293
Q

Tx for OIS

A

Carotid Endarterectomy (stenosis of >70 or AF, TIA, non disabling stroke). PRP or anti-VEGF.

294
Q

OIS prognosis

A

POOR.

295
Q

OIS vs. CRVO

A

Venous dilated only in OIS but tortousity in CRVO. Hemorrhages in NFL pole in CRVO. Peripheral in D&B in OIS. Delayed choroidal fillingOIS Normal in CRVO. Arterial staining more than vein with OIS. Vein more than artery in CRVO. Normal ON in OIS. Swollen ON in CRVO.

OC DZ 3rd year (2 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions